102 results
Page 2 of 6
8-K
EX-99.1
f5qcxf4co 7rtmhmtv
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
0fzjo1yt70
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
j96mfrp 7a
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
2su6fo9uzp73f
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
jhx6 22ka
28 Sep 22
Business combination disclosure
6:01am
425
io1cj 6q868a48dkavu
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.1
3p7i 3zc84lbo
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
EX-99.3
6lnk93 ypfhanf1
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
i01bnyh9yt8usyk
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-99.1
stz8my0
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
0mln0
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
EX-99.1
dugg oard
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K
EX-99.1
mc2le0cree u03j8
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
EX-99.1
crdra xs3aemi2gusc
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
EX-99.1
1005jr62a1 nb0
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-99.1
wrkpxi7b3
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.2
0glvvn
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am